Found: 9
Select item for more details and to access through your institution.
Comments on: "A Systematic Review and Meta‑analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Efficacy of Collagenase Clostridium histolyticum (Xiapex®) in Patients with the Acute Phase of Peyronie's Disease.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 583, doi. 10.1007/s40261-020-00916-4
- By:
- Publication type:
- Article
Tumor-Agnostic Treatment for Cancer: When How is Better than Where.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 519, doi. 10.1007/s40261-020-00915-5
- By:
- Publication type:
- Article
Comparative Study of Traditional Ablative CO2 Laser-Assisted Topical Antifungal with only Topical Antifungal for Treating Onychomycosis: A Multicenter Study.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 575, doi. 10.1007/s40261-020-00914-6
- By:
- Publication type:
- Article
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 511, doi. 10.1007/s40261-020-00917-3
- By:
- Publication type:
- Article
Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 555, doi. 10.1007/s40261-020-00909-3
- By:
- Publication type:
- Article
Clinical Drug-Drug Interaction Studies to Evaluate the Effects of a P-Glycoprotein Inhibitor, CYP3A Inhibitors, and a CYP3A Inducer on the Pharmacokinetics of Naldemedine in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 529, doi. 10.1007/s40261-020-00902-w
- By:
- Publication type:
- Article
Comparison of Anti-factor Xa Activity Among Three Different Factor Xa Inhibitors in Non-valvular Atrial Fibrillation Patients with Renal Impairment.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 567, doi. 10.1007/s40261-020-00912-8
- By:
- Publication type:
- Article
A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 541, doi. 10.1007/s40261-020-00907-5
- By:
- Publication type:
- Article